NDC 52544-348 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52544-348
- Package NDCs from labels
- 52544-348-30, 52544-348-01, 52544-348-05, 52544-348-10
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets USP Rx only | Watson Laboratories, Inc. | 2008-01-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52544-348-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 52544-348-05 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 52544-348-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 52544-348-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2025-12-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDE | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 261dd83f-8048-488f-8b71-c4abd9692720 | 2025-12-10 | Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Sun Pharmaceutical Industries, Inc. | d7fa3c79-9f26-415b-8039-eb2acabcf66b | 2025-12-09 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma Inc | 578f74ea-53d1-4c44-b872-66033292abe0 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma Inc | ff7b2d81-9006-465d-9095-1bd8696a12a6 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 5bacc909-6b02-4815-85ef-55fd25b1b1f7 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Cadista Pharmaceuticals Inc. | e0b74a86-3d36-1af0-e538-41b45b8d2cc3 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril/HCTZ | LISINOPRIL/HCTZ | Direct_Rx | 4510c108-2683-f505-e063-6394a90ab0a4 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | QPharma Inc | f795db5e-d5ef-4a20-e053-6394a90a7fda | 2025-12-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f5f462c6-0604-49d3-af8f-fecbde23be99 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Hikma Pharmaceuticals USA Inc. | 17561aae-f0bc-4ffc-a007-985b17e9baf0 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene | TRIAMTERENE CAPSULES | TRUPHARMA LLC | fea50328-b3d5-4300-8c67-82cda0a975b7 | 2025-12-01 | Warnings, Adverse reactions | WS821Z52LQ |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | e6527adf-8c74-4d81-9199-d56a7fca895e | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYZAAR | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Organon LLC | 4116ccde-2e23-45f4-b12f-6337df877744 | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | 515f735c-5dba-43d9-8a58-97a319cafd56 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | 6d677f9e-c0e4-4d6e-bea2-a58e986e4635 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0937d511-4d5e-4aba-bfae-92094c67bcf4 | 2025-11-20 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.